BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 376128)

  • 1. Methotrexate and central nervous system toxicity.
    Abelson HT
    Cancer Treat Rep; 1978 Dec; 62(12):1999-2001. PubMed ID: 376128
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of the white matter following prophylactic therapy of the central nervous system for leukemia: radiation effects and methotrexate leukoencephalopathy.
    Shalen PR; Ostrow PT; Glass PJ
    Radiology; 1981 Aug; 140(2):409-12. PubMed ID: 6942436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and toxicity of preventive treatment with cranial irradiation and intrathecal methotrexate on the central nervous system in childhood lymphoblastic leukemia].
    Ortega JJ; Javier G; Montagut JM
    Sangre (Barc); 1983; 28(1):24-38. PubMed ID: 6575484
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain damage in relation to irradiation and chemotherapy of central nervous system.
    Similä S; Heikkinen E; Blanco G; Taskinen PJ; Kouvalainen K; Lanning M; Saukkonen AL
    Lancet; 1977 May; 1(8019):1000-1. PubMed ID: 67432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results obtained in children with acute lymphoblastic leukemia in a period of 10 years with the combination of polychemotherapy and radiotherapy of the central nervous system].
    Aur RJ; Hustu HO; Verzosa MS; Simone JV; Pinkel D
    Sangre (Barc); 1973; 18(4):449-54. PubMed ID: 4525501
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic methotrexate toxicity to the central nervous system.
    Shapiro WR; Allen JC; Horten BC
    Clin Bull; 1980; 10(2):49-52. PubMed ID: 6893169
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukemia of childhood.
    Wehinger H; Slanina J; Jacobi H; Musshoff K; Dietz V; Sauer M; Dilger M
    Strahlentherapie; 1974 Dec; 148(6):590-8. PubMed ID: 4532340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Involvement of the central nervous system at the onset of acute lymphoblastic leukemia in children. Clinical and instrumental investigation].
    Galletti F; Sturniolo MG; Crocioni F; De Giorgis G; Moleti L; Cristiani ML; Benedetti P
    Minerva Pediatr; 1984 Sep; 36(17):825-30. PubMed ID: 6596487
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurologic sequelae of methotrexate and ionizing radiation: a new classification.
    Bleyer WA
    Cancer Treat Rep; 1981; 65 Suppl 1():89-98. PubMed ID: 6948611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of intrathecal methotrexate prophylaxis and treatment of central nervous system leukemia in children.
    Kobayashi Y; Ishigame Y; Hara M; Nitta Y; Higaki T
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):107-13. PubMed ID: 1071901
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate, folate and the brain.
    Kamen BA
    Neurotoxicology; 1986; 7(2):209-16. PubMed ID: 3097592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rare complications in the course of leukemia on the central nervous system].
    Korczowski R; Nizankowska-Blaz T
    Pediatr Pol; 1976 Aug; 51(8):985-7. PubMed ID: 1067561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukoencephalopathy in childhood leukemia (author's transl)].
    Laurian Y; Cau D; Jacque C; Breton MP; Dommergues JP; Tchernia G
    Nouv Rev Fr Hematol (1978); 1981; 23(5):291-7. PubMed ID: 6949138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of leukemia of the central nervous system. Results of different therapeutic methods and toxic effects].
    Pavlovsky S; Garay G; Fisman N
    Sangre (Barc); 1981; 26(2):197-202. PubMed ID: 7025271
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotoxicities of current leukemia therapy.
    Pizzo PA; Poplack DG; Bleyer WA
    Am J Pediatr Hematol Oncol; 1979; 1(2):127-40. PubMed ID: 396797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency].
    Netter JC; Dhondt JL; Rance F; Petrus M
    Arch Fr Pediatr; 1991 Dec; 48(10):719-22. PubMed ID: 1793349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurotoxicity of intrathecal methotrexate administration and external meningoencephalic irradiation in carcinomatous meningitis. Must one reconsider therapeutic technics for meningitis in acute lymphoblastic leukemias and non-Hodgkin's lymphomas?].
    Touboul E; Fauchon F; Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1981; 23(5):299-301. PubMed ID: 6949139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroleukemia--prophylaxis and treatment].
    Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Jun; 37(3):136-9. PubMed ID: 6755625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylactic central nervous system therapy in childhood leukemia and its complications].
    Tsukimoto I
    Rinsho Ketsueki; 1988 Apr; 29(4):449-56. PubMed ID: 3165476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylactic treatment of meningeal leukemia (author's transl)].
    Stryckmans PA; Malarme M
    Rev Med Brux; 1981 Mar; 2(3):281-92. PubMed ID: 7015445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.